Podoplanin overexpression has been detected in wide range of tumor cells, including squamous cell carcinoma [27], mesothelioma [28], glioblastoma [29], bladder cancer [30], angiosarcoma [31], brain tumors [32], testicular seminoma [33], and osteosarcoma [34]. Here, PDPN is linked to urinary bladder carcinoma.